[{"id":"addf9881-649b-4b14-a5d4-bee09c226217","acronym":"","url":"https://clinicaltrials.gov/study/NCT02919046","created_at":"2021-01-18T14:19:47.678Z","updated_at":"2024-07-02T16:37:24.395Z","phase":"","brief_title":"Study Evaluating the Efficacy and Safety With CAR-T for Relapsed or Refractory Neuroblastoma in Children","source_id_and_acronym":"NCT02919046","lead_sponsor":"Sinobioway Cell Therapy Co., Ltd.","biomarkers":" MYCN","pipe":" | ","alterations":" MYCN amplification","tags":["MYCN"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MYCN amplification"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GD2-targeted CAR-T cells"],"overall_status":"Unknown status","enrollment":" Enrollment 22","initiation":"Initiation: 09/01/2016","start_date":" 09/01/2016","primary_txt":" Primary completion: 09/01/2020","primary_completion_date":" 09/01/2020","study_txt":" Completion: 09/01/2020","study_completion_date":" 09/01/2020","last_update_posted":"2017-03-14"}]